Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Eye Care

Journal Scan / Research · March 08, 2017

The Role of the Human Visual Cortex in Assessing the Durability of Retinal Gene Therapy in RPE65 Trial Patients

Ophthalmology

 

Additional Info

Ophthalmology
The Role of the Human Visual Cortex in Assessment of the Long-Term Durability of Retinal Gene Therapy in Follow-On RPE65 Clinical Trial Patients
Ophthalmology 2017 Feb 22;[EPub Ahead of Print], M Ashtari, ES Nikonova, KA Marshall, GJ Young, P Aravand, W Pan, GS Ying, AE Willett, M Mahmoudian, AM Maguire, J Bennett

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading